LONDON The number of new drugs approved for sale in United States and Europe has bounced back this year, suggesting a marked slowdown in 2016 was an aberration rather than a sign of flagging research and development productivity.
- U.S. Alzheimer's deaths jump 54 percent; many increasingly dying at home
- Deadly brain infection in German MS patient prompts Roche investigation
- Activists call on In-N-Out Burger to join the superbug fight
- Red meat tied to higher risk of dying from many diseases
- Does telling patients of possible side effects make them more likely?
People who wear activity trackers to count the calories they're burning are probably not getting accurate estimates, suggests a new study.
FORTALEZA, Brazil Researchers in Brazil are experimenting with a new treatment for severe burns using the skin of tilapia fish, an unorthodox procedure they say can ease the pain of victims and cut medical costs.
MUMBAI India's plan to bring in a law to ensure doctors prescribe medicines only by their generic names risks proliferating the sale of substandard drugs in a country where regulation is already lax, doctors and pharmaceutical executives say.
WASHINGTON U.S. Senate Majority Leader Mitch McConnell said on Wednesday he does not yet know how Republicans will amass the votes needed to pass legislation now being crafted to dismantle Obamacare, but expressed some optimism on another top priority, overhauling the tax code. | Video